DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Decoy Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.17+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $622.40K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 9, 2026 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 18, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 15, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jun 17, 2024 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Jun 14, 2024 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Oct 17, 2022 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Oct 14, 2022 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jul 22, 2019 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |